2023 - In Vitro Diagnostics for Early Cancer Detection: The Evolution and Promise of Liquid Biopsy Technology
Date2023-05-25
Deadline2023-05-25
VenueWebinar, USA - United States
KeywordsEarly Detection; Liquid Biopsy; Diagnostics
Topics/Call fo Papers
As liquid biopsies become more commonplace, gaining wider US Food and Drug Administration (FDA) acceptance and even becoming standard of care in some instances, the technology is giving rise to important new questions. In this webinar, the featured speakers will explore the technique’s growing importance in early cancer detection and address common questions about its use.
The webinar will provide insights into developing an in vitro diagnostics test for early cancer detection with clinical, analytical and performance validation considerations. Attendees will learn how to approach single indication vs. multi-cancer screen indications, the advantages and disadvantages of lab-developed tests vs. premarket approval and the regulatory landscape for in vitro diagnostics. In addition, discover strategies for operationalizing large-scale clinical validation studies.
Join this webinar on in vitro diagnostics for early cancer detection for a discussion on the evolution and promise of liquid biopsy technology.
The webinar will provide insights into developing an in vitro diagnostics test for early cancer detection with clinical, analytical and performance validation considerations. Attendees will learn how to approach single indication vs. multi-cancer screen indications, the advantages and disadvantages of lab-developed tests vs. premarket approval and the regulatory landscape for in vitro diagnostics. In addition, discover strategies for operationalizing large-scale clinical validation studies.
Join this webinar on in vitro diagnostics for early cancer detection for a discussion on the evolution and promise of liquid biopsy technology.
Other CFPs
- Real-World Data By Design — Incorporating Different Data Types into Clinical Trials
- Reducing Caregiver Burden in Alzheimer’s Disease Clinical Trials to Boost Patient Recruitment
- Bringing Clinical Trial Access to Underserved Populations in a Community Setting
- Antibody Reduction in Bioprocessing: Analytical Detection and Steps for Mitigation
- Digital Endpoint Development for Alzheimer’s Disease: The Importance of Patients as Partners
Last modified: 2023-05-09 06:04:40